午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Struktur
62258-12-2
CAS-Nr.
62258-12-2
Englisch Name:
GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC
Synonyma:
LND-2;LDFH II;LNDFH II;Lewis a (Lea) hexaose;lacto-n-difucohexoseii;LACTO-N-DIFUCOHEXAOSE-2;LACTO-N-DIFUCOHEXAOSE II;Lacto-N-difucopentaose II;LACTO-N-DIFUCOSYLHEXAOSE II;Lacto-N-difucohexaose II ,95%
CBNumber:
CB5197767
Summenformel:
C38H65NO29
Molgewicht:
999.91
MOL-Datei:
62258-12-2.mol

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Eigenschaften

Siedepunkt:
1366.0±65.0 °C(Predicted)
Dichte
1.71±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
pka
12.20±0.20(Predicted)

Sicherheit

Kennzeichnung gef?hrlicher B
WGK Germany  3
10-21

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

LND-2

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 32)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19552 58
J & K SCIENTIFIC LTD. 18210857532
jkinfo@jkchemical.com China 96815 76
Hangzhou Dingyan Chem Co., LTD 0571-87157530-8008 17369838938
sales@dingyanchem.com China 2180 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
3008007409@qq.com China 71826 60
Chengdu Push Bio-Technology Co., Ltd. 028-85370565-229 18080489829
3004654993@qq.com China 8816 60
BOC Sciences 16314854226
inquiry@bocsci.com United States 9713 58
Wuhan Tangzhi Pharmaceutical Co., Ltd. 027-63498076 13658392159
sale@glycogene.com China 832 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62321 58
Chengdu Push Bio-Technology Co., Ltd. 18080489829
3004654993@qq.com China 9209 58
Shanghai Yingxin Laboratory Equipment Co., Ltd. 021-021-59178156 17002132182
3146474380@qq.com China 11603 58

62258-12-2()Verwandte Suche:


  • lacto-n-difucohexoseii
  • LACTO-N-DIFUCOHEXAOSE II FROM*HUMAN MILK
  • β-d-gal-(1→3)-[α-l-fuc-(1→4)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-[α-l-fuc-(1→3)]-d-glc
  • Lacto-N-difucopentaose II
  • N-[(2R,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,5-trihydroxy-6-oxo-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-hexan-3-yl]oxy-oxan-4-yl]oxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl]acetamide
  • LNH, β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc
  • Lacto-N-difucohexaose II ,95%
  • LACTO-N-DIFUCOHEXAOSE-2
  • LACTO-N-DIFUCOSYLHEXAOSE II
  • LACTO-N-DIFUCOHEXAOSE II
  • LDFH II
  • LND-2
  • LNDFH II
  • BETA-D-GAL-[1->3]-(ALPHA-L-FUC-[1->4])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-D-GLC
  • GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC
  • Lacto-N-difucohexaose II(Lewisa hexaose)(LNDFH-II)
  • D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-
  • Lewis a (Lea) hexaose
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on BSA
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT B)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT C)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin and fluorescein (Linker-BT-FLUO A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin and stearic chain (Linker-BT-STEA A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on CRM197
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with DBCO (Linker-DBCO A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to desthiobiotin (Linker-DBT-A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to fluorescein (Linker-FLUO A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on gel for affinity chromatography (Linker-GEL A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on gel for affinity chromatography (Linker-GEL B)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on HSA
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on KLH
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with cyclic di-thiol (Linker-LIPO A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to maleimide (Linker-MAL A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal azide (Linker-N3 A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal azide (Linker-N3 B)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 A) Hydrochloride form
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 B)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 C)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 D)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on OVA
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with customizable dual functionalization
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with stearic chain (Linker-STEA A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH A)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH B)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH C)
  • Lacto-N-difucohexaose II (Le a hexa)
  • Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR)
  • N-((2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,5-trihydroxy-6-oxo-4-(((2R,3R,4S,6R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide
  • 62258-12-2
  • Carbohydrate Analysis
  • Carbohydrates
  • Carbohydrate Standards
  • Biochemicals and Reagents
  • BioChemical
  • Oligosaccharide
  • Post-translational Modification
  • Proteomics and Protein Expression
Copyright 2019 ? ChemicalBook. All rights reserved